Friday, October 2, 2026 — Week 40
CENSUS — 1,871 AND GROWING
Q3 census: 1,871 known patients, +65 this quarter.
First patient in Rwanda. USA +11, China +16, Brazil +6, France +4.
Finding patients matters more than ever as trials approach. https://cureSYNGAP1.org/Census
COMBINEDBRAIN — RARE RESEARCH ROUNDTABLE
Wonderful Rare Research Roundtable on Genetic Neurodevelopmental Disorders. COMBINEDBrain is a gift to the rare neuro community — hug them when you see them. https://combinedbrain.org/RR-RGND
Dr. Emma James of Encoded, chair of our IAB, posted about the meeting.
CURE SYNGAP1 CONFERENCE — DENVER
9 Family Legacy Sponsors, up from 8 in 2025.
Thursday Rare Reception — free, register: https://cureSYNGAP1.org/RR26
Friday Family Dinner at Henry’s: https://cureSYNGAP1.org/Henrys
Conference registration ends OCT. 31. https://cureSYNGAP1.org/Reg26
UNLOCK THEIR TOMORROW
Q4 goal: $500,000 by Dec. 31, including a $200,000 match.
Families can start their own fundraiser; anyone can donate. https://cureSYNGAP1.org/Unlock
Your Idea. Your Fundraiser. Your SYNGAP1 Impact. https://curesyngap1.org/blog/your-ide…
COMMUNITY ACTION
RARE Disease Week 2027, March 2-4, in DC. Travel reimbursement applications are open; deadline Nov. 6. https://bit.ly/4jo7fku
RARE Foundation travel reimbursement post
Sign up for ARI: https://cureSYNGAP1.org/Ari
WARRIORS — JACK
Jack is a 3-year-old from Berkeley who missed early milestones and was diagnosed with SYNGAP1 around age 3 after eyelid-fluttering episodes led to EEG, MRI and genetic testing. https://curesyngap1.org/syngap-warriors/jack-w/
NEWSLETTER #52
All the latest news and links in one place: https://cureSYNGAP1.org/NL52
Subscribe: https://cureSYNGAP1.org/Newsletter
PUBMED + SCIENCE
PubMed 2026: 54. +14 vs Week 40. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date
USA – Use your ICD-10: F78.A1
SOCIAL MATTERS
5,301 LinkedIn — https://www.linkedin.com/company/curesyngap1
1.63k YouTube — https://www.youtube.com/channel/UCtnPWPpqouMA_1UGOyu4W6A
11k X – https://x.com/cureSYNGAP1
43.4k Instagram — https://www.instagram.com/curesyngap1
Like and subscribe wherever you listen. https://curesyngap1.org/podcasts/syngap10/
Episode 222 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
Below is a transcript from the video:
[00:00:01] Hello, Syngap Land. My name is Mike Graglia, and this is episode 222 of the CURE SYNGAP1 podcast. Today is Friday, October 2nd, 2026. We’re in week 40 of the year. Like clockwork, the incredible census team led by Jess Duggan posted an update yesterday on October 1st for the fourth quarter of 2026. We are up to 1,871 patients and growing around the world. That reflects a plus 65 for the past quarter. That’s pretty good because our average is about plus 50. So plus 65 tells you that things are happening. And when you double-click on the numbers, you see plus 11 in the U.S., plus 16 in China, plus 6 in Brazil, plus 4 in France, and 1 in Rwanda.
[00:00:35] There was a study of kids with severe, severely affected disabled kids in Africa, and they found a bunch of patients, including Syngapian. So just reinforces what I’ve been saying. You will find a Syngapian anywhere you test disabled kids. You will find a Syngapian anywhere you test disabled kids or adults, for that matter. With trials approaching and industry and investors paying more and more attention, finding patients really matters.
So I want you to go to this blog. If you go to curesyngap1.org/census, you can find the blog for 1871.
[00:01:09] If you read that, you can click into another blog, and then there’s a link to a spreadsheet, and you can see which countries are finding patients. There are certain countries that are not updating those numbers. I’m telling you guys, at the minimum, as a patient advocacy group, we need to know how many patients we have, and keeping those numbers updated is critical.
So I want to thank Jess Duggan for her incredible work, this and leading it in the U.S. And then, you know, 1,871. And to that poor kid in Rwanda who has the mutation they have, we’re thinking about you.
[00:01:42] I don’t know how you function in Rwanda with SYNGAP, but hopefully, as a community, we’ll be able to find that kid and help him at some point.
This week, I spent Monday and Tuesday in Washington, D.C., at the COMBINEDBrain Research Roundtable for Rare Genetic Neurodevelopmental Disorders, the RR-RGND, which is one of the most ridiculous acronyms ever. It’s not even an acronym. It’s just like a letter soup, but it was an incredible, and a research roundtable is where researchers and scientists and clinicians come together to discuss an issue in D.C., and members of the FDA leave the FDA and come into a hotel and sit, and we talk about these things together.
[00:02:23] And this meeting was a huge labor of love led by Terry Jo Bichell, who is the CEO and founder of COMBINEDBrain, who is the mother of 21-ish-year-old Louie [unclear], who has Angelman, and is just a fearless, tireless saint who fights for all rare diseases. And I, I just cannot tell you enough how impressed I am with Terry Jo, with COMBINEDBrain, and now with this meeting was a new high. And everybody from industry partners to FDA.
[00:02:51] Representatives reflected on what an impressive meeting it was, and I’m really honored that I got to go. There were a handful of us, I put a picture of us on the copy of this pod, who were on the board of COMBINEDBrain, and we were, by virtue of that, able to attend this meeting. And it was a real honor and really a real win for the SYNGAP community because I did talk to some FDA reps about SYNGAP and what’s coming and a bunch of stuff. And, um, it was good. We were there. It was a win. It was a win.
So, um, and don’t take my word for it.
[00:03:18] Dr. Emma James, who is a pretty senior over at Encoded and the chairman of the Industry Advisory Board for COMBINEDBrain, posted about the meeting on LinkedIn. Link’s in the show notes. Please read it. It was a win. It was good. And I definitely earned my paycheck, which, for reference, is zero dollars. But if it was bigger than zero dollars, I would have earned it on Monday and Tuesday because this was a great, great meeting.
Speaking of great, great meetings, we have the CURE SYNGAP1 conference coming up in Denver on December 3rd and 4th. That is two short months away, folks. We’re at 60 days. It’s not too late to register. Too late to register will be the end of this month.
[00:03:52] October 31st is when registration for the conference goes away. You have four things to do. Register for the conference. Get a hotel room and book your flights. Register for the Rare Reception on Thursday night, free. So we have industry sponsors it, and we have a big reception on Thursday night. There’s five other rare groups working, having parallel conferences. We’re all doing this together. We’re hosting a wonderful reception on Thursday night. Please join us. It’s free.
On Friday night, not free. We’re having family dinner. We bought out a restaurant and not.
[00:04:24] Free, but we lose money every year, so you’re, you’re, you’re gonna get more than you pay for that one. And, and please join us for family dinner on Friday night. It’s just a great way to end the two days and the day of Family Day.
So, um, CURE SYNGAP1 conference in Denver. Join us. The way, the reason we can lose money, by the way, is our sponsors. So we have industry sponsors, but we also have families in the community who write checks for a couple thousand dollars. Maybe it’s three or four, I honestly don’t know. And, and these are called Family Legacy Sponsors, and we have nine of those this year. That’s 35,000-ish the, the, the organization is taking in to.
[00:04:53] Help defray the costs of, of, of the direct costs, not the end. I don’t even charge the indirect cost, just the direct cost of running this conference. So thank you to those nine families. I’ll name them next. I think I’m one. I hope I’m one. I’m one of them.
But join us on the Thursday Rare Reception. Join us on the Friday family dinner. Book the conference. If you’re on the, if you’re on the fence, call us. We should all be there.
Speaking of incredibly generous families, there is a family, not mine, which is wonderful, who has committed $200,000. More on them later, but they have committed $200,000 in matching funds for Unlock Their Tomorrow.
[00:05:27] Unlock Their Tomorrow is our Q4 year-end fundraising campaign where we say to the community, hey, let’s raise some money, right? You’re like, oh my gosh, Mike, you’re always trying to raise money. You have the gala in Q1. You have the, you have the, it was Q2. You have the Sprint for SYNGAP. You’re doing all these little events. And now you expect us to shake the trees and raise half a million dollars in Q4. Damn right.
Do you have any idea how much work we’ve got ahead of us? We now have to fight for endpoints. We have to get more companies involved. We have to support more science.
[00:05:57] We have to start thinking about regulatory and access, getting regulators to approve this drug and getting people to pay for this drug. The amount of work that is before us is gargantuan. And step one is raise the money so SYNGAP1 can continue to be front and center.
So please, in the next three months, think about how you’re going to raise money for CURE SYNGAP1 and know that the first $200,000 we raise will be matched by this generous family. Let’s not miss that huge opportunity. Go to CURE SYNGAP1.org, unlock, start a fundraiser. It’s go time, folks. There’s also a blog in here I share about all the different fundraisers you can do. Check them out.
[00:06:33] I want to give you more things to do. Rare Disease Week 2027. So I just talked about what you can do for the next quarter, but Rare Disease Week is in early ’27. I want to say March or April. I don’t have it in my notes. I should have that. But I want you to go to Rare Disease Week.
And here’s the thing. Rare Disease Week is run by the Rare Foundation, which used to be called the EveryLife Foundation, but they rebranded, and I think it was a great idea. And, um, this is where you go. There’s a huge meeting, hundreds of people in the room.
[00:07:02] They train us on all the issues, and then they organize us, and they book appointments for us. And then we go with, like, people from our states. You’ll have SYNGAP people, STX people, Dravet people, LGS people, all the people. We’ll go to the congressman from Colorado’s office and then to the senator from Colorado’s office, et cetera. I’ll be the Colorado people, the California, all the people.
This is a huge event. This is the day when rare disease is heard on the Hill. And until we have our own SYNGAP day, and even when we have our own SYNGAP day, we’re still going to do this because this is a great event. And our friends at Rare are powerful allies who we need.
[00:07:33] So I want you to go to that. Here’s the good news. There is travel support. So if you’re like, I would love to do that. I would love to meet my congresspeople. I would love to talk about SYNGAP, but I can’t afford to fly to D.C. and stay in a hotel. Don’t worry. You don’t have to. You can apply right now. Link’s in the show notes under Community Action. Apply right now for a travel grant to go to Rare on the Hill.
And here’s the secret to Rare on the Hill. If you’re applying from California or Texas or Florida or huge states where there’s a lot of people, maybe you’ll get it, maybe you won’t. I don’t know.
[00:07:59] Might be first come, first serve. Might be need. I don’t know. If you’re applying from a state where not a lot of people go, you’re much more likely to get it because they want representatives from all the states because congresspeople and senators are from all the states. And it’s much harder to get rare disease people from these states.
So if you are from, I don’t want to pick on states, but you know where you’re from. If you’re from a place where you don’t think there’s a lot of kids with rare disease, definitely apply for a Rare travel grant. You might get it, and then you can come and help raise awareness for SYNGAP1 on the Hill in early 2027.
[00:08:28] Links in the show notes. There’s a Facebook link from Rare Reception. Also, if you haven’t signed up for ARI, we’ve talked about ARI ad nauseam. There’s a webinar in the, um, newsletter. Check it out. You sign for ARI Warriors. We have Warrior Wednesdays every week.
There’s a beautiful profile on Jack. Jack’s a three-year-old from Berkeley who was diagnosed. Team Jack is a remarkable organ group of parents and clinicians who take care of this beautiful little boy. Read about Jack.
Newsletter 52 is up. This is a gargantuan lift for Ed. He does it so well. I’m so glad it’s not my job anymore. CURE SYNGAP1.org slash NL52, NL52. Read the newsletter. It’s got everything in it. Check it out, including, uh, the webinar we did about ARI.
[00:09:02] Um, PubMed is at 54 for the week. That’s plus, that’s plus 14. Here’s the thing about PubMed. PubMed is all the publications that have ever been written about SYNGAP since the gene was discovered in 1998. There’s about 411 papers in there, round numbers. This year, we’ve got 54 papers. Last year, it was 60. A year before that, 54. A year before that, 40-something. You add that up, you’re north of 200. That means that half the knowledge about SYNGAP1, half the knowledge about SYNGAP1, and about 13% of the knowledge of SYNGAP1, this year.
[00:09:42] In the past four years, we’ve had half the publications ever on SYNGAP1. In the past year, this year to date, the past nine months, we’ve had about 12%. That is the speed at which SYNGAP is happening, and that has a lot to do with us. So good job, team. Keep it up. Stay tuned. I’ll see you next week.